Home/Pipeline/TJC0667

TJC0667

Inflammatory disorders

PreclinicalActive

Key Facts

Indication
Inflammatory disorders
Phase
Preclinical
Status
Active
Company

About TaiwanJ Pharmaceuticals

TaiwanJ develops small‑molecule drugs for liver and inflammatory diseases using proprietary TLR4/Autotaxin platforms.

View full company profile